Collectively, our findings suggest that downregulation of MKL-1 notably augments the anti-tumor efficacy of the ferroptosis inducer Erastin in gastric cancer cells, thereby implying a role for MKL-1 in the regulation of ferroptosis in gastric cancer. Here, MRTFA is linked to neoplasm.